CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ EQUITY - USD ($) shares in Millions, $ in Millions | Total | Cumulative Effect, Period of Adoption, Adjustment | Common Stock | Additional Paid-In Capital | Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment | Accumulated Other Comprehensive Loss | Retained Earnings | Retained Earnings Cumulative Effect, Period of Adoption, Adjustment |
Beginning balance (in shares) at Jul. 01, 2022 | 0 | | | | | | | |
Beginning balance at Jul. 01, 2022 | $ 0 | | | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | 0 | | | | | | | |
Ending balance at Sep. 30, 2022 | $ 0 | | | | | | | |
Common stock, beginning balance (in shares) at Jul. 01, 2022 | | | 315 | | | | | |
Beginning balance at Jul. 01, 2022 | 12,323 | $ (37) | $ 3 | $ 3,733 | $ (128) | $ (579) | $ 9,166 | $ 91 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | 47 | | | | | | 47 | |
Employee stock plans (in shares) | | | 3 | | | | | |
Employee stock plans | (50) | | | (50) | | | | |
Stock-based compensation | 86 | | | 86 | | | | |
Foreign currency translation adjustment | (87) | | | | | (87) | | |
Net unrealized gain (loss) on derivative contracts | (60) | | | | | (60) | | |
Common stock, ending balance (in shares) at Sep. 30, 2022 | | | 318 | | | | | |
Ending balance at Sep. 30, 2022 | $ 12,222 | | $ 3 | 3,641 | | (726) | 9,304 | |
Beginning balance (in shares) at Jul. 01, 2022 | 0 | | | | | | | |
Beginning balance at Jul. 01, 2022 | $ 0 | | | | | | | |
Ending balance (in shares) at Mar. 31, 2023 | 1 | | | | | | | |
Ending balance at Mar. 31, 2023 | $ 876 | | | | | | | |
Common stock, beginning balance (in shares) at Jul. 01, 2022 | | | 315 | | | | | |
Beginning balance at Jul. 01, 2022 | 12,323 | $ (37) | $ 3 | 3,733 | $ (128) | (579) | 9,166 | $ 91 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | (975) | | | | | | | |
Common stock, ending balance (in shares) at Mar. 31, 2023 | | | 320 | | | | | |
Ending balance at Mar. 31, 2023 | $ 11,741 | | $ 3 | 3,831 | | (375) | 8,282 | |
Beginning balance (in shares) at Sep. 30, 2022 | 0 | | | | | | | |
Beginning balance at Sep. 30, 2022 | $ 0 | | | | | | | |
Ending balance (in shares) at Dec. 30, 2022 | 0 | | | | | | | |
Ending balance at Dec. 30, 2022 | $ 0 | | | | | | | |
Common stock, beginning balance (in shares) at Sep. 30, 2022 | | | 318 | | | | | |
Beginning balance at Sep. 30, 2022 | 12,222 | | $ 3 | 3,641 | | (726) | 9,304 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | (451) | | | | | | (451) | |
Employee stock plans (in shares) | | | 1 | | | | | |
Employee stock plans | 43 | | | 43 | | | | |
Stock-based compensation | 86 | | | 86 | | | | |
Foreign currency translation adjustment | 117 | | | | | 117 | | |
Net unrealized gain (loss) on derivative contracts | 228 | | | | | 228 | | |
Common stock, ending balance (in shares) at Dec. 30, 2022 | | | 319 | | | | | |
Ending balance at Dec. 30, 2022 | $ 12,245 | | $ 3 | 3,770 | | (381) | 8,853 | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | |
Issuance of Convertible preferred stock, net of issuance costs (in shares) | 1 | | | | | | | |
Issuance of convertible preferred stock, net of issuance costs | $ 876 | | | | | | | |
Ending balance (in shares) at Mar. 31, 2023 | 1 | | | | | | | |
Ending balance at Mar. 31, 2023 | $ 876 | | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | (571) | | | | | | (571) | |
Employee stock plans (in shares) | | | 1 | | | | | |
Employee stock plans | (13) | | | (13) | | | | |
Stock-based compensation | 74 | | | 74 | | | | |
Actuarial pension gain | (1) | | | | | (1) | | |
Foreign currency translation adjustment | (9) | | | | | (9) | | |
Net unrealized gain (loss) on derivative contracts | 16 | | | | | 16 | | |
Common stock, ending balance (in shares) at Mar. 31, 2023 | | | 320 | | | | | |
Ending balance at Mar. 31, 2023 | $ 11,741 | | $ 3 | 3,831 | | (375) | 8,282 | |
Beginning balance (in shares) at Jun. 30, 2023 | 1 | | | | | | | |
Beginning balance at Jun. 30, 2023 | $ 876 | | | | | | | |
Ending balance (in shares) at Sep. 29, 2023 | 1 | | | | | | | |
Ending balance at Sep. 29, 2023 | $ 876 | | | | | | | |
Common stock, beginning balance (in shares) at Jun. 30, 2023 | 322 | | 322 | | | | | |
Beginning balance at Jun. 30, 2023 | $ 10,964 | | $ 3 | 3,936 | | (548) | 7,573 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | (685) | | | | | | (685) | |
Employee stock plans (in shares) | | | 2 | | | | | |
Employee stock plans | (43) | | | (43) | | | | |
Stock-based compensation | 77 | | | 77 | | | | |
Foreign currency translation adjustment | (38) | | | | | (38) | | |
Net unrealized gain (loss) on derivative contracts | (45) | | | | | (45) | | |
Common stock, ending balance (in shares) at Sep. 29, 2023 | | | 324 | | | | | |
Ending balance at Sep. 29, 2023 | $ 10,230 | | $ 3 | 3,970 | | (631) | 6,888 | |
Beginning balance (in shares) at Jun. 30, 2023 | 1 | | | | | | | |
Beginning balance at Jun. 30, 2023 | $ 876 | | | | | | | |
Ending balance (in shares) at Mar. 29, 2024 | 1 | | | | | | | |
Ending balance at Mar. 29, 2024 | $ 876 | | | | | | | |
Common stock, beginning balance (in shares) at Jun. 30, 2023 | 322 | | 322 | | | | | |
Beginning balance at Jun. 30, 2023 | $ 10,964 | | $ 3 | 3,936 | | (548) | 7,573 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | $ (837) | | | | | | | |
Common stock, ending balance (in shares) at Mar. 29, 2024 | 326 | | 326 | | | | | |
Ending balance at Mar. 29, 2024 | $ 10,121 | | $ 3 | 4,018 | | (636) | 6,736 | |
Beginning balance (in shares) at Sep. 29, 2023 | 1 | | | | | | | |
Beginning balance at Sep. 29, 2023 | $ 876 | | | | | | | |
Ending balance (in shares) at Dec. 29, 2023 | 1 | | | | | | | |
Ending balance at Dec. 29, 2023 | $ 876 | | | | | | | |
Common stock, beginning balance (in shares) at Sep. 29, 2023 | | | 324 | | | | | |
Beginning balance at Sep. 29, 2023 | 10,230 | | $ 3 | 3,970 | | (631) | 6,888 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | (287) | | | | | | (287) | |
Employee stock plans (in shares) | | | 2 | | | | | |
Employee stock plans | 33 | | | 33 | | | | |
Stock-based compensation | 72 | | | 72 | | | | |
Purchase of capped calls related to the issuance of convertible notes, net of tax | (118) | | | (118) | | | | |
Foreign currency translation adjustment | 58 | | | | | 58 | | |
Net unrealized gain (loss) on derivative contracts | 80 | | | | | 80 | | |
Common stock, ending balance (in shares) at Dec. 29, 2023 | | | 326 | | | | | |
Ending balance at Dec. 29, 2023 | $ 10,068 | | $ 3 | 3,957 | | (493) | 6,601 | |
Ending balance (in shares) at Mar. 29, 2024 | 1 | | | | | | | |
Ending balance at Mar. 29, 2024 | $ 876 | | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | |
Net(loss) income | 135 | | | | | | 135 | |
Employee stock plans | (16) | | | (16) | | | | |
Stock-based compensation | 77 | | | 77 | | | | |
Foreign currency translation adjustment | (75) | | | | | (75) | | |
Net unrealized gain (loss) on derivative contracts | $ (68) | | | | | (68) | | |
Common stock, ending balance (in shares) at Mar. 29, 2024 | 326 | | 326 | | | | | |
Ending balance at Mar. 29, 2024 | $ 10,121 | | $ 3 | $ 4,018 | | $ (636) | $ 6,736 | |